Current
$1.01T
5-Year Average
$548.38B
All-Time High
$1.04T
All-Time Low
$30.07B
Market cap daily chart for Eli Lilly (LLY)
Jun 16, 2021 – Jun 15, 2026 · 1,255 trading days
Market Cap growth chart for Eli Lilly (LLY) from 1985 to 2026
Latest: +4.8%
Market Cap history table for Eli Lilly (LLY) from 1985 to 2026
| 2026 | $1.01T | +4.8% | +$46.72B | ||
| 2025 | $965.06B | +38.3% | +$267.13B | ||
| 2024 | $697.93B | +32.6% | +$171.39B | ||
| 2023 | $526.54B | +51.5% | +$178.93B | ||
| 2022 | $347.61B | +32.0% | +$84.20B | ||
| 2021 | $263.42B | +63.1% | +$101.91B | ||
| 2020 | $161.51B | +28.3% | +$35.66B | ||
| 2019 | $125.85B | +5.2% | +$6.23B | ||
| 2018 | $119.62B | +34.6% | +$30.76B | ||
| 2017 | $88.85B | +9.7% | +$7.88B | ||
| 2016 | $80.97B | -13.1% | −$12.16B | ||
| 2015 | $93.13B | +21.5% | +$16.51B | ||
| 2014 | $76.62B | +34.5% | +$19.67B | ||
| 2013 | $56.96B | +0.7% | +$411.51M | ||
| 2012 | $56.55B | +22.1% | +$10.25B | ||
| 2011 | $46.30B | +19.5% | +$7.55B | ||
| 2010 | $38.75B | -1.2% | −$475.00M | ||
| 2009 | $39.22B | -11.0% | −$4.85B | ||
| 2008 | $44.08B | -24.3% | −$14.16B | ||
| 2007 | $58.24B | +2.8% | +$1.61B | ||
| 2006 | $56.62B | -8.5% | −$5.27B | ||
| 2005 | $61.89B | +0.0% | +$11.15M | ||
| 2004 | $61.88B | -18.6% | −$14.11B | ||
| 2003 | $75.99B | +10.5% | +$7.21B | ||
| 2002 | $68.78B | -19.7% | −$16.84B | ||
| 2001 | $85.62B | -16.0% | −$16.37B | ||
| 2000 | $101.99B | +38.7% | +$28.44B | ||
| 1999 | $73.55B | -26.1% | −$26.03B | ||
| 1998 | $99.58B | +26.5% | +$20.86B | ||
| 1997 | $78.72B | +93.1% | +$37.95B | ||
| 1996 | $40.77B | +23.2% | +$7.67B | ||
| 1995 | $33.11B | +72.7% | +$13.94B | ||
| 1994 | $19.17B | +7.6% | +$1.35B | ||
| 1993 | $17.82B | +0.9% | +$167.63M | ||
| 1992 | $17.65B | -27.4% | −$6.65B | ||
| 1991 | $24.29B | +15.3% | +$3.23B | ||
| 1990 | $21.06B | +4.7% | +$945.06M | ||
| 1989 | $20.12B | +65.7% | +$7.98B | ||
| 1988 | $12.14B | +8.3% | +$934.65M | ||
| 1987 | $11.21B | +10.3% | +$1.05B | ||
| 1986 | $10.16B | +32.3% | +$2.48B | ||
| 1985 | $7.68B | — | — |
- 2026$1.01T+4.8%
- 2025$965.06B+38.3%
- 2024$697.93B+32.6%
- 2023$526.54B+51.5%
- 2022$347.61B+32.0%
- 2021$263.42B+63.1%
- 2020$161.51B+28.3%
- 2019$125.85B+5.2%
- 2018$119.62B+34.6%
- 2017$88.85B+9.7%
- 2016$80.97B-13.1%
- 2015$93.13B+21.5%
- 2014$76.62B+34.5%
- 2013$56.96B+0.7%
- 2012$56.55B+22.1%
- 2011$46.30B+19.5%
- 2010$38.75B-1.2%
- 2009$39.22B-11.0%
- 2008$44.08B-24.3%
- 2007$58.24B+2.8%
- 2006$56.62B-8.5%
- 2005$61.89B+0.0%
- 2004$61.88B-18.6%
- 2003$75.99B+10.5%
- 2002$68.78B-19.7%
- 2001$85.62B-16.0%
- 2000$101.99B+38.7%
- 1999$73.55B-26.1%
- 1998$99.58B+26.5%
- 1997$78.72B+93.1%
- 1996$40.77B+23.2%
- 1995$33.11B+72.7%
- 1994$19.17B+7.6%
- 1993$17.82B+0.9%
- 1992$17.65B-27.4%
- 1991$24.29B+15.3%
- 1990$21.06B+4.7%
- 1989$20.12B+65.7%
- 1988$12.14B+8.3%
- 1987$11.21B+10.3%
- 1986$10.16B+32.3%
- 1985$7.68B—
Market Cap values are taken from Eli Lilly's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Eli Lilly (LLY)
According to Eli Lilly's latest reported financial statements, the company's latest reported market cap is $824.02B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2026, Eli Lilly (LLY) market cap totalled $1.01T – edged up 4.8% year-over-year.
Over 2021–2026 (5 years), Eli Lilly market cap expanded at a +30.9% compound annual rate, sustaining 10 straight years of year-over-year growth.
2026 marks the peak market cap at $1.01T, with the historical low of $7.68B recorded in 1985.
Eli Lilly Market Cap by Year
Eli Lilly Market Cap 2026: $1.01T
In 2026, Eli Lilly reported market cap of $1.01T, edged up 4.8% from 2025. This figure represents the highest annual value in the available history.
Eli Lilly Market Cap 2025: $965.06B
Eli Lilly market cap in 2025 was $965.06B, surged 38.3% from 2024.
Eli Lilly Market Cap 2024: $697.93B
2024's market cap for Eli Lilly came in at $697.93B, surged 32.6% from 2023.
Eli Lilly Market Cap 2023: $526.54B
Eli Lilly posted market cap of $526.54B in 2023, surged 51.5% from 2022.
Eli Lilly Market Cap 2022: $347.61B
Eli Lilly market cap in 2022 was $347.61B.
See more financial history for Eli Lilly (LLY).
Sector peers by Market Cap
Healthcare peers of Eli Lilly (LLY), ranked by their latest market cap
| $567.28B | |
| $391.50B | |
| $373.28B | |
| $283.78B | |
| $274.92B | |
| $195.17B | |
| $189.18B | |
| $176.04B |
- $567.28B
- $391.50B
- $373.28B
- $283.78B
- $274.92B
- $195.17B
- $189.18B
- $176.04B
Frequently asked questions
Eli Lilly (LLY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation